Dr Reddy's completes acquisition of UK co Haleon's non-US nicotine replacement therapy biz
Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine replacement therapy (NRT) business for GBP 458 million. The deal includes brands like Nicotinell,
Dr Reddy's completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. This includes top brands like Nicotinell, Nicabate, Thrive, and Habitrol,
Dr Reddy’s invests $620 million in Swiss subsidiary for Nicotinell brand acquisition
Drug maker Dr Reddy's Laboratories Ltd on Friday (September 27) said it has invested $620 million in its wholly-owned subsidiary, Dr Reddy’s Laboratories SA, Switzerland (DRL SA). This investment aligns with the company’s earlier board-approved fund infusion of up to ￡500 million ($640 million) to acquire the Nicotinell brand and related assets from the Haleon Group.
Dr. Reddy's Laboratories Completes $620-Million Investment In Switzerland Unit
The funds infused by the company into Dr. Reddy's SA will be used for the acquisition of Nicotinell and related brands.
Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global portfolio of consumer healthcare brands, outside of the US, in the Nicotine Replacement Therapy (NRT) category.
Business Line2d
Dr Reddy’s completes acquisition of Haleon Plc’s global portfolio of consumer healthcare brands in NRT
Dr Reddy’s Laboratories SA, Switzerland, an arm of Dr Reddy’s Laboratories, has completed the previously-announced ...
Dr. Reddy's Laboratories Stocks Live Updates: Dr. Reddy's Laboratories Posts 3.03% Weekly Increase, Closing at Rs 6749.90
Stay updated with the Dr. Reddy's Laboratories Stock Liveblog, your one-stop destination for real-time information and ...
The Week1d
Dr Nilay Reddy of Hyderabad LV Prasad Eye Hospital dies in Outer Ring Road car accident
Dr. Nilay Reddy, 29, a Cornea and Anterior Segment Fellow at the LV Prasad Eye Hospital, was travelling to the airport from ...
Dr. Reddy's Laboratories rises Thursday, still underperforms market
Shares of Dr. Reddy's Laboratories Ltd. 500124 inched up 0.74% to 6,743.20 Indian rupees Thursday, on what proved to be an ...
Dr. Reddy's Laboratories Share Price Today Updates: Dr. Reddy's Laboratories Sees Minor Daily Decline Amid Positive Six-Month Returns
Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your ultimate source for real-time updates and analysis of one of the ...
Dr Reddy's completes acquisition of Haleon's global NRT portfolio
DRL's Swiss subsidiary completed the acquisition through the purchase of shares of Northstar Switzerland SARL, a Haleon group ...
Dr. Reddy's Laboratories outperforms competitors on strong trading day
Dr. Reddy's Laboratories Ltd. 500124 shares inched up 0.64% to 6,693.65 Indian rupees Wednesday, on what proved to be an ...
Sell Dr Reddy's, Lupin, Zydus Life, Auro Pharma shares, says UBS, sees up to 20% downside
Global brokerage firm UBS has initiated coverage on as many has half dozen Indian Pharma counters and has suggested to sell ...